Library search
Navigating the Headwaters of Intellectual Property Risk in
the Pharmaceutical Industry
Intellectual property litigation may feel like familiar ground to many competitors in the pharmaceutical drug, medical device, nutraceutical, and other prescription markets. Yet intellectual property laws frequently interact in ways...Read more
Simon Jenner
General Partner, Baker Jenner, USA
The Evolution of In-house Legal & IP Departments
It is not the strongest of the species that survives, nor the most intelligent. It is the one that is most adaptable to change. This quote, likely incorrectly attributed to...Read more
Michael Kock
Head IP, Syngenta International AG, Switzerland
'The Past, the Present, and the Future … Clinical Trials and the Contract Research Organisation (CRO)'
In 2016, Clinical Trials globally are performed to ensure safe and efficacious treatment which meet ethical principles, but will these principles meet the challenges of the future? To understand how...Read more
Helen Fovargue
Assistant General Counsel, Iqvia, UK
The new EFPIA Disclosure Code – Is the Need for Transparency Outweighing Data Privacy Compliance?
European Federation of Pharmaceutical Industries and Associations (EFPIA) adopted on 24 June 2013, the EFPIA Disclosure Code, that is a code of conduct which obliges its member companies, from 2016,...Read more
John Giannakakis
Regional Counsel Southern Europe , G4s Rms , Greece
South Africa as a Destination of Choice for International Dispute Resolution
South Africa is a land of dichotomies. Whilst being the commercial hub of the continent, and having what is widely regarded as the most advanced Constitution in the world, it...Read more
Howard Snoyman
Head: Legal and Ethics, Discovery Health Medical Scheme, South Africa
Being Social: The FDA Pronounces on Interactive Promotional Media
In the United States, consumers are increasingly turning to social media to obtain information about pharmaceutical products and devices, to research medical conditions, and obtain information about potential treatments, available...Read more
Marianne Slivkova
Senior Corporate Counsel, Acorda Therapeutics, USA
Mediation as a Dispute Resolution Mechanism in High Tech Industry Collaborations: A Look at Pharma and Biotech
Alternative Dispute Resolution (ADR) in the pharmaceuticals and biotech industries should be looked at - as much as a means for saving on legal cost and managing litigation risk -...Read more
Jukka Muhonen
Director, Global Business Dev.& Alliance Management, Orion Corporation, Finland
A Path Through the Forest - The Role of Agency Guidance in Developing Regulatory Compliance Programs
Counsel involved in developing regulatory compliance programs know that merely looking at the statute and regulations is not enough. They need to look to multiple sources of information to determine...Read more
Jack Sorokin
Adjunct Instructor, Fremont College, USA
Pharmaceutical Marketing and Transparency in Japan
Japan is a promising market for companies, in-spite of the pressures posed by drug prices, competition and patents. The reason may be the large growth of pharmaceuticals, an aging population,...Read more
Marianne Slivkova
Senior Corporate Counsel, Acorda Therapeutics, USA
Digital Media in the Pharmaceutical Industry: Oportunities and Legal Challenges
The term digital media is widely understood. According to the open-access encyclopedia Wikipedia digital media shall mean a “form of electronic media where data are stored in digital (as opposed...Read more
Marc Bauer
Legal Director, AMGEN (Europe) GmbH, Switzerland